AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 152 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $141,000 | +6.8% | 10,452 | -6.5% | 0.00% | -25.0% |
| Q3 2020 | $132,000 | -19.0% | 11,178 | +1.1% | 0.00% | -20.0% |
| Q2 2020 | $163,000 | -35.8% | 11,054 | +5.3% | 0.01% | +25.0% |
| Q4 2019 | $254,000 | -33.9% | 10,500 | -47.5% | 0.00% | -50.0% |
| Q3 2019 | $384,000 | -35.0% | 20,000 | 0.0% | 0.01% | -50.0% |
| Q2 2019 | $591,000 | -64.5% | 20,000 | -42.9% | 0.02% | -61.0% |
| Q1 2019 | $1,663,000 | +15.2% | 35,000 | -12.5% | 0.04% | -31.7% |
| Q4 2018 | $1,444,000 | -22.1% | 40,000 | +32.8% | 0.06% | +22.4% |
| Q3 2018 | $1,854,000 | -21.6% | 30,118 | -13.9% | 0.05% | -14.0% |
| Q2 2018 | $2,364,000 | -3.2% | 35,000 | -22.2% | 0.06% | -26.0% |
| Q1 2018 | $2,441,000 | -25.7% | 45,000 | -18.2% | 0.08% | -8.3% |
| Q4 2017 | $3,286,000 | +35.2% | 55,000 | +10.0% | 0.08% | -6.7% |
| Q3 2017 | $2,430,000 | -7.5% | 50,000 | 0.0% | 0.09% | -18.9% |
| Q2 2017 | $2,628,000 | -12.2% | 50,000 | -24.2% | 0.11% | -6.7% |
| Q1 2017 | $2,993,000 | +19.8% | 66,000 | 0.0% | 0.12% | -1.7% |
| Q4 2016 | $2,498,000 | +32.4% | 66,000 | +32.0% | 0.12% | +3.4% |
| Q3 2016 | $1,887,000 | +502.9% | 50,000 | +400.0% | 0.12% | +735.7% |
| Q1 2015 | $313,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|